Incannex Healthcare Limited
General ticker "IXHL" information:
- Sector: Health Care
- Industry: Drug Manufacturers - Specialty & Generic
- Capitalization: $19.6M (TTM average)
Incannex Healthcare Limited does not follow the US Stock Market performance with the rate: -13.3%.
Estimated limits based on current volatility of 6.8%: low 0.40$, high 0.44$
Factors to consider:
- Total employees count: 5 as of 2022
- Current price 61.5% below estimated low
- Earnings for 12 months up through Q4 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-06-30 to 2026-06-30
- 2024-06-30 to 2025-06-30 estimated range: [1.75$, 5.01$]
- 2025-06-30 to 2026-06-30 estimated range: [1.06$, 3.31$]
Financial Metrics affecting the IXHL estimates:
- Positive: with PPE of -2.8 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -30.21 <= 0.33
- Negative: negative Industry operating cash flow (median)
- Positive: Investing cash flow per share per price, % of -0.53 > -0.66
- Negative: negative Net income
- Negative: negative Industry operating income (median)
Short-term IXHL quotes
Long-term IXHL plot with estimates
Financial data
| YTD | 2023-06-30 | 2024-06-30 | 2025-06-30 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.02MM | $0.09MM |
| Operating Expenses | $13.64MM | $44.99MM | $23.88MM |
| Operating Income | $-13.64MM | $-44.97MM | $-23.79MM |
| Non-Operating Income | $-35.17MM | $17.38MM | $-23.10MM |
| Interest Expense | $0.00MM | $0.00MM | $0.30MM |
| R&D Expense | $6.31MM | $19.28MM | $10.75MM |
| Income(Loss) | $-48.81MM | $-27.59MM | $-46.88MM |
| Taxes | $0.00MM | $0.04MM | $-1.76MM |
| Profit(Loss)* | $-48.81MM | $-18.46MM | $-46.88MM |
| Stockholders Equity | $20.82MM | $11.22MM | $13.39MM |
| Assets | $23.78MM | $17.05MM | $20.45MM |
| Operating Cash Flow | $-10.75MM | $-15.85MM | $-12.51MM |
| Capital expenditure | $0.32MM | $0.28MM | $0.01MM |
| Investing Cash Flow | $-0.32MM | $-0.28MM | $-0.01MM |
| Financing Cash Flow | $9.00MM | $0.14MM | $21.40MM |
| Earnings Per Share** | $-3.17 | $-1.14 | $-1.36 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.